DISCOUNT ZERTIFIKAT - BIOGEN IDEC | Market Closed - Boerse Frankfurt Warrants 01:40:13 2024-05-31 pm EDT | ||
| 202.6 EUR | +2.47% |
|
| 1 month | +1.59% | ||
| 3 months | +1.85% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 202.6 | +2.47% |
| 24-05-30 | 197.7 | +0.98% |
| 24-05-29 | 195.8 | -0.11% |
| 24-05-28 | 196 | -0.53% |
| 24-05-27 | 197 | -0.13% |
Real-time Boerse Frankfurt Warrants
Last update May 31, 2024 at 01:40 pm EDT
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM8BYH |
| ISIN | DE000VM8BYH4 |
| Date issued | 2024-01-10 |
| Maturity | 2024-12-20 (202 Days) |
| Parity | 1 : 1 |
| Emission price | 211.4 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 213.1 € |
|---|---|
| Lowest since issue | 177.6 € |
| Spread | 0.21 € |
| Spread % | 0.10% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
224.9
USD
Average target price
284.8
USD
Spread / Average Target
+26.60%
- Stock Market
- Certificates
- Certificat
